Rene Russo - 15 Apr 2025 Form 4 Insider Report for Xilio Therapeutics, Inc. (XLO)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Kevin Brennan, Attorney-in-Fact
Issuer symbol
XLO
Transactions as of
15 Apr 2025
Net transactions value
$0
Form type
4
Filing time
16 Apr 2025, 16:30:17 UTC
Previous filing
18 Jun 2025
Next filing
18 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XLO Stock Option (right to buy) Award $0 +190,000 $0.000000 190,000 15 Apr 2025 Common Stock 190,000 $0.7120 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on April 15, 2025 and will vest in equal monthly installments beginning on May 1, 2025 through April 1, 2029.